Daniel Jenny specialises in M&A transactions, capital markets, corporate restructurings as well as general corporate and commercial matters (e.g. joint ventures, shareholders' agreements). He is active in various sectors, including Private Equity/Venture Capital, TMC and Life Science & Healthcare.
Besides his vast experience in a broad range of national and international M&A and private equity transactions, Daniel Jenny represents investors and startups in venture capital investments and financing rounds. He also has a broad experience in corporate restructurings, including distressed M&A (e.g. purchase of companies in insolvency proceedings). Further, he advises on corporate governance, in particular concerning questions on directors' liability. In his fields of expertise, Daniel Jenny often represents clients in corporate litigation such as post M&A, directors' liability or other corporate disputes (e.g. special audits or challenge of shareholders' resolutions).
After his traineeship with CMS and his clerkship with the District Court of Zurich, Daniel Jenny was admitted to the bar in 2007 and has since been working as a lawyer with CMS. He gained additional work experience as an international associate in a New York-based law firm and as legal counsel with an industrial multinational (Hilti AG). Daniel Jenny has authored various legal publications. His thesis "Means of Defence of Board Members in Directors' Liability Lawsuits", approved by the University of Zurich in 2012 (summa cum laude), was awarded with the Professor Walther Hug prize. Daniel Jenny has been constantly recommended in legal directories such as Chambers and Partners, The Legal 500 and IFLR1000.